KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $29.9 million.

  • Exact Sciences' Capital Expenditures rose 1429.39% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.7 million, marking a year-over-year increase of 381.44%. This contributed to the annual value of $136.0 million for FY2024, which is 950.08% up from last year.
  • Exact Sciences' Capital Expenditures amounted to $29.9 million in Q3 2025, which was up 1429.39% from $42.3 million recorded in Q2 2025.
  • Exact Sciences' Capital Expenditures' 5-year high stood at $72.9 million during Q4 2022, with a 5-year trough of $18.3 million in Q3 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $34.7 million (2023), whereas its average is $37.6 million.
  • In the last 5 years, Exact Sciences' Capital Expenditures tumbled by 8364.08% in 2021 and then skyrocketed by 14390.47% in 2022.
  • Exact Sciences' Capital Expenditures (Quarter) stood at $59.4 million in 2021, then grew by 22.7% to $72.9 million in 2022, then crashed by 52.08% to $34.9 million in 2023, then grew by 3.99% to $36.3 million in 2024, then fell by 17.68% to $29.9 million in 2025.
  • Its last three reported values are $29.9 million in Q3 2025, $42.3 million for Q2 2025, and $31.2 million during Q1 2025.